Saturday, July 11, 2026

Drug profile · INN

insulin isophane human

insulin isophane human (HUMULIN NPH) is a insulin receptor agonist. Associated with NovoThirteen.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — insulin isophane human

Quick answer

insulin isophane human (HUMULIN NPH) is a insulin receptor agonist. Associated with NovoThirteen.

Key facts

INN insulin isophane human
Brand HUMULIN NPH
Mechanism Insulin receptor agonist
Target Insulin receptor
Originator NovoThirteen

Mechanism of action

Insulin receptor agonist

Primary target: Insulin receptor

Approval history

Authority Status Date
TGA approved

Related & competitor drugs

  1. insulin aspart Alimentary tract and metabolism (A10)
  2. insulin aspart protamine recombinant Insulin receptor agonist
  3. insulin aspart recombinant Insulin receptor agonist
  4. insulin degludec Alimentary tract and metabolism (A10)
  5. insulin detemir Alimentary tract and metabolism (A10)
  6. insulin detemir recombinant Insulin receptor agonist

Frequently asked questions

What is insulin isophane human?

insulin isophane human (HUMULIN NPH) is a insulin receptor agonist. Associated with NovoThirteen.

What is the brand name for insulin isophane human?

HUMULIN NPH is a marketed brand name for insulin isophane human. Check FDA Drugs@FDA for the current US label holder and prescribing information.